DarioHealth Corp. (DRIO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, DarioHealth Corp. reported revenue of $22.36M, down 17.3% from the prior year. The company ran a net loss, with a net margin of -186.6% and a gross margin of 56.6%.
Key ratios (FY2025)
56.6%
Gross margin
-163.9%
Operating margin
-186.6%
Net margin
-61.4%
Return on equity
-17.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.36M | $27.04M | $20.35M | $27.66M | $20.51M | $7.58M | $7.56M | $7.39M | — | — |
| Cost of Revenue | $9.69M | $13.77M | $14.37M | $18.00M | $16.55M | $5.06M | $4.96M | $5.63M | $3.86M | — |
| Gross Profit | $12.66M | $13.27M | $5.98M | $9.65M | $3.96M | $2.51M | $2.60M | $1.76M | $1.31M | -$830.0K |
| Operating Income | -$36.66M | -$57.74M | -$56.19M | -$56.81M | -$76.49M | -$29.90M | -$17.70M | -$17.69M | -$14.42M | -$11.10M |
| Net Income | -$41.71M | -$42.75M | -$59.43M | -$62.19M | -$76.76M | -$29.45M | -$17.74M | -$17.80M | -$15.74M | -$10.89M |
| EPS (Diluted) | $10.12 | $12.27 | $1.93 | $2.54 | $4.07 | $4.01 | — | — | — | — |
| Total Assets | $110.08M | $118.88M | $96.39M | $119.19M | $100.77M | $35.41M | $24.57M | $14.09M | $6.96M | $3.87M |
| Shareholders' Equity | $67.92M | $72.02M | $58.14M | $80.00M | $85.55M | $28.15M | $18.89M | $8.93M | $3.94M | -$6.54M |
| Cash & Equivalents | $21.80M | $27.76M | $36.80M | $49.36M | $35.81M | $28.59M | $20.39M | $11.00M | $3.72M | $1.09M |
| Operating Cash Flow | -$25.94M | -$38.56M | -$30.38M | -$47.84M | -$50.41M | -$17.74M | -$15.72M | -$11.47M | -$10.62M | -$8.38M |
| Capital Expenditures | $142.0K | $138.0K | $584.0K | $442.0K | $261.0K | $118.0K | $98.0K | $71.0K | $195.0K | $808.0K |
| Shares Outstanding | 6.91M | 1.92M | 27.19M | 25.72M | 16.57M | 8.12M | 2.24M | 1.83M | 14.07M | 5.71M |